Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Clinical Trial

Research Support, U.S. Gov't, Non-P.H.S.

Clinical Trial, Phase II

Review

Clinical Trial, Phase IV

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2019

2014

2013

2012

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""14-alpha Demethylase Inhibitors""[mesh_terms]

10 Results

Searching titles within these results

Drug-induced gynecomastia: an evidence-based review.

Glenn D Braunstein, Fnu Deepinder

Expert opinion on drug safety 2013;11(5):779-95

Full Text

Abstract

The effect of treatment with ketoconazole on central CRH systems of depressed patients.

Georgios Paslakis, Olivera Lecei, Günther K Stalla, Rainer Landgraf, Manfred Uhr, Bettina Hamann, Peter Luppa, Maria Gilles, Isabella Heuser, Michael Deuschle

Human psychopharmacology 2013;26(1):35-40

Full Text

Abstract

A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis.

Stephen R Brand, Thorsten P Degenhardt, Karen Person, Jack D Sobel, Paul Nyirjesy, Robert J Schotzinger, Amir Tavakkol

American journal of obstetrics and gynecology 2019;218(6):624.e1-624.e9

Full Text

Abstract

Lack of drug interaction between the migraine drug MAP0004 (orally inhaled dihydroergotamine) and a CYP3A4 inhibitor in humans.

D Kellerman, S Kori, A Forst, J Chang, S Febbraro, L Wutann, T Thomas, G Taylor, Dw Dodick

Cephalalgia : an international journal of headache 2012;32(2):150-8

Full Text

Abstract

Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole.

M Y Roth, J J S Nya-Ngatchou, K Lin, S T Page, B D Anawalt, A M Matsumoto, B T Marck, W J Bremner, J K Amory

The Journal of clinical endocrinology and metabolism 2013;98(3):1198-206

Free Full Text

Abstract

Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study.

Malcolm J Boyce, Kathy J Baisley, Steven J Warrington

British journal of clinical pharmacology 2012;73(3):411-21

Free Full Text

Abstract

CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast.

Tiina Karonen, Pertti J Neuvonen, Janne T Backman

British journal of clinical pharmacology 2012;73(2):257-67

Free Full Text

Abstract

Lomitapide at supratherapeutic plasma levels does not prolong the Qtc interval--results from a TQT study with moxifloxacin and ketoconazole.

Mark Sumeray, Philip Sager, Georg Ferber, Borje Darpo, Meijian Zhou

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2014;18(6):577-89

Free Full Text

Abstract

Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects.

Susan E Shoaf, Patricia Bricmont, Suresh Mallikaarjun

British journal of clinical pharmacology 2012;73(4):579-87

Free Full Text

Abstract

Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin.

Joachim Troost, Shinji Tatami, Yasuhiro Tsuda, Michaela Mattheus, Ludwig Mehlburger, Martina Wein, Martin C Michel

British journal of clinical pharmacology 2012;72(2):247-56

Free Full Text

Abstract

Results: 1 – 10 / 10

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""14-alpha Demethylase Inhibitors""[mesh_terms]

Drug-induced gynecomastia: an evidence-based review.

The effect of treatment with ketoconazole on central CRH systems of depressed patients.

A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis.

Lack of drug interaction between the migraine drug MAP0004 (orally inhaled dihydroergotamine) and a CYP3A4 inhibitor in humans.

Androgen synthesis in the gonadotropin-suppressed human testes can be markedly suppressed by ketoconazole.

Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study.

CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast.

Lomitapide at supratherapeutic plasma levels does not prolong the Qtc interval--results from a TQT study with moxifloxacin and ketoconazole.

Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects.

Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin.

Results for
""14-alpha Demethylase Inhibitors""[mesh_terms]